Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 5, 2000

View Archived Issues

Pharmos presents positive results from head trauma trial

MorphoSys and ImmunoGen begin human antibodies alliance

Alza to acquire Crescendo

Coulter obtains rights to technology related to RA treatment

Novo Nordisk's liquid Norditropin now available in U.S.

FDA approves breath-activated device with corticosteroid for asthma

Health Canada allows extension of paclitaxel trial for MS

IND filed by Endovasc for Liprostin

Preclinical studies indicate potential for ISAtx-247 in diabetes treatment

Pain Therapeutics reports promising phase II clinical trial results for new pain treatment

Oncolytic compound shows promise as cytomegalovirus therapy

Novel neuregulin polypeptide which promotes neuronal survival or growth

Antimalarial antibodies designed at EntreMed

Vascular-damaging combretastatin derivatives and their use in treating tumors

Synthesis and activity of phenyl pyrrolidinone glutamate antagonists described by Eisai

More potential GH secretagogues patented by Lilly

Lilly describes new series acting on the serotonergic system

Cathepsin inhibitors claimed by AstraZeneca for use in COPD

SB presents cathepsin K inhibitors and their use

New cyclic amide compounds synthesized at Japanese lab act as selective M3 antagonists

Intranasal IM-862 enters phase III

First prescription drug to treat unwanted facial hair introduced in U.S.

New antiretroviral treatment option available from Abbott

New inhibitor of cathepsin K and bone resorption reduces bone turnover in primate model

Ciba Vision and QLT seek to expand Visudyne indication in the E.U.

Beneficial effects of Ro-26-9228 on bone coupled with minimal effects on Ca homeostasis

Dual MMP/TACE inhibitor provides significant neuroprotection in bacterial meningitis

Final analysis of ISIS-2302 sparks reinitiation of development

New azasordarins characterized in several ICAAC presentations

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 23, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...